Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5182469
Max Phase: Preclinical
Molecular Formula: C54H79N15O12S2Se
Molecular Weight: 1273.41
Associated Items:
ID: ALA5182469
Max Phase: Preclinical
Molecular Formula: C54H79N15O12S2Se
Molecular Weight: 1273.41
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)CCCn2[se]c3ccccc3c2=O)C(=O)N[C@@H](CCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1)C(=O)O
Standard InChI: InChI=1S/C54H79N15O12S2Se/c1-29(2)24-39(53(80)81)66-50(77)41-28-83-82-27-40(61-43(71)18-11-23-69-52(79)33-13-5-7-17-42(33)84-69)49(76)63-37(19-21-56)47(74)62-36(16-10-22-59-54(57)58)45(72)65-38(25-31-26-60-34-14-6-4-12-32(31)34)48(75)68-44(30(3)70)51(78)64-35(46(73)67-41)15-8-9-20-55/h4-7,12-14,17,26,29-30,35-41,44,60,70H,8-11,15-16,18-25,27-28,55-56H2,1-3H3,(H,61,71)(H,62,74)(H,63,76)(H,64,78)(H,65,72)(H,66,77)(H,67,73)(H,68,75)(H,80,81)(H4,57,58,59)/t30-,35+,36+,37+,38+,39+,40+,41+,44+/m1/s1
Standard InChI Key: WHERELHRQKRTGQ-OHDPMZIGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1273.41 | Molecular Weight (Monoisotopic): 1273.4639 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Liu J, Xu S, Huang C, Shen J, Yu S, Yu Y, Sun Q, Dai Q.. (2022) Synthesis and activity evaluation of selenazole-coupled CPI-1 irreversible bifunctional inhibitors for botulinum toxin A light chain., 73 [PMID:35914651] [10.1016/j.bmcl.2022.128913] |
Source(1):